Kellogg (K) 10-Q 3 Nov 22 2022 Q3 Quarterly report Financial data

Cover Page

Cover Page	9 Months Ended
	Oct. 01, 2022 shares
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Entity Registrant Name	KELLOGG COMPANY
Document Period End Date	Oct. 01, 2022
Document Transition Report	false
Entity File Number	1-4171
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	38-0710690
Entity Address, Address Line One	One Kellogg Square
Entity Address, Address Line Two	P.O. Box 3599
Entity Address, City or Town	Battle Creek
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	49016-3599
City Area Code	269
Local Phone Number	961-2000
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)	341,281,145
Amendment Flag	false
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Entity Central Index Key	0000055067
Current Fiscal Year End Date	--12-31
Common stock
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, $.25 par value per share
Trading Symbol	K
Security Exchange Name	NYSE
0.800% Senior Notes Due 2022 [Member]
Entity Information [Line Items]
Title of 12(b) Security	0.800% Senior Notes due 2022
Trading Symbol	K 22A
Security Exchange Name	NYSE
1.000% Senior Notes Due 2024 [Member]
Entity Information [Line Items]
Title of 12(b) Security	1.000% Senior Notes due 2024
Trading Symbol	K 24
Security Exchange Name	NYSE
1.250% Senior Notes Due 2025 [Member]
Entity Information [Line Items]
Title of 12(b) Security	1.250% Senior Notes due 2025
Trading Symbol	K 25
Security Exchange Name	NYSE
0.500% Senior Notes Due 2029
Entity Information [Line Items]
Title of 12(b) Security	0.500% Senior Notes due 2029
Trading Symbol	K 29
Security Exchange Name	NYSE

Consolidated Balance Sheet (Una

Consolidated Balance Sheet (Unaudited) - USD ($) $ in Millions	Oct. 01, 2022	Jan. 01, 2022
Current assets
Cash and cash equivalents	$ 373	$ 286
Accounts receivable, net	1,985	1,489
Inventories	1,682	1,398
Other current assets	404	221
Total current assets	4,444	3,394
Property, net	3,564	3,827
Operating lease right-of-use assets	608	640
Goodwill	5,691	5,771
Other intangibles, net	2,302	2,409
Investments in unconsolidated entities	427	424
Other assets	1,980	1,713
Total assets	19,016	18,178
Current liabilities
Current maturities of long-term debt	816	712
Notes payable	174	137
Accounts payable	2,871	2,573
Current operating lease liabilities	111	116
Accrued advertising and promotion	813	714
Accrued salaries and wages	317	300
Other current liabilities	931	763
Total current liabilities	6,033	5,315
Long-term debt	5,697	6,262
Operating lease liabilities	478	502
Deferred income taxes	923	722
Pension liability	603	706
Other liabilities	544	456
Commitments and contingencies
Equity
Common stock, $.25 par value	105	105
Capital in excess of par value	1,027	1,023
Retained earnings	9,499	9,028
Treasury stock, at cost	(4,750)	(4,715)
Accumulated other comprehensive income (loss)	(1,598)	(1,721)
Total Kellogg Company equity	4,283	3,720
Noncontrolling interests	455	495
Total equity	4,738	4,215
Total liabilities and equity	$ 19,016	$ 18,178

Consolidated Balance Sheet (U_2

Consolidated Balance Sheet (Unaudited) (Parenthetical) - $ / shares	Oct. 01, 2022	Jan. 01, 2022
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.25	$ 0.25

Consolidated Statement of Incom

Consolidated Statement of Income (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 01, 2022	Oct. 02, 2021
Income Statement [Abstract]
Net sales	$ 3,946	$ 3,622	$ 11,482	$ 10,761
Cost of goods sold	2,793	2,457	8,027	7,206
Selling, general and administrative expense	785	718	2,155	2,132
Operating profit	368	447	1,300	1,423
Interest expense	39	55	149	172
Other income (expense), net	54	0	188	155
Income before income taxes	383	392	1,339	1,406
Income tax expense (benefit)	74	92	283	345
Earnings (loss) from unconsolidated entities	3	5	6	0
Net income	312	305	1,062	1,061
Net income attributable to noncontrolling interests	2	(2)	4	6
Net income attributable to Kellogg Company	$ 310	$ 307	$ 1,058	$ 1,055
Per share amounts:
Basic earnings (in dollars per share)	$ 0.91	$ 0.90	$ 3.11	$ 3.09
Diluted earnings (in dollars per share)	$ 0.90	$ 0.89	$ 3.09	$ 3.07
Average shares outstanding:
Basic (in shares)	341,000	341,000	340,000	341,000
Diluted (in shares)	344,000	343,000	343,000	343,000
Actual shares outstanding at period end (in shares)	341,000	341,000	341,000	341,000

Consolidated Statement of Compr

Consolidated Statement of Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 01, 2022	Oct. 02, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 312	$ 305	$ 1,062	$ 1,061
Other comprehensive income (loss), pre-tax:
Foreign currency translation adjustments, pre-tax	(249)	(103)	(509)	(150)
Net investment hedges, pre-tax
Net investment hedge gain (loss), pre-tax	260	87	616	175
Cash flow hedges, pre-tax:
Unrealized gain (loss) on cash flow hedges, pre-tax	62	3	213	42
Reclassification to net income, pre-tax	(14)	4	(6)	19
Postretirement and postemployment benefits reclassification to net income, pre-tax:
Net experience (gain) loss	0	0	(2)	(2)
Available-for-sale securities, pre-tax
Unrealized gain (loss) on available-for-sale securities, pre-tax	(2)	0	(6)	(1)
Reclassification to net income on available-for-sale securities, pre-tax	1	(2)	1	(2)
Other comprehensive income (loss), pre-tax	58	(11)	307	81
Other comprehensive income (loss), tax (expense) benefit
Foreign currency translation adjustments, tax (expense) benefit	4	2	6	2
Net investment hedges, tax (expense) benefit
Net investment hedge gain (loss), tax (expense) benefit	(68)	(23)	(162)	(46)
Cash flow hedges, tax (expense) benefit:
Unrealized gain (loss) on cash flow hedges, tax (expense) benefit	(16)	(1)	(56)	(11)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	3	(1)	1	(5)
Postretirement and postemployment benefits reclassification to net income, tax (expense) benefit:
Net experience loss, tax (expense) benefit	0	0	1	1
Available-for-sale securities, tax (expense) benefit
Unrealized gain (loss) on available-for-sale securities, tax (expense) benefit	0	0	0	0
Reclassification to net income on available for sale of securities, tax (expense) benefit	0	0	0	0
Other comprehensive income (loss), tax (expense) benefit	(77)	(23)	(210)	(59)
Other comprehensive income (loss), after tax:
Foreign currency translation adjustments, after-tax	(245)	(101)	(503)	(148)
Net investment hedges, after tax
Net investment hedge gain (loss), after-tax	192	64	454	129
Cash flow hedges, after tax
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax	46	2	157	31
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax	(11)	3	(5)	14
Postretirement and postemployment benefits reclassification to net income, after-tax:
Net experience (gain) loss, after-tax	0	0	(1)	(1)
Available-for-sale securities, after tax
Unrealized gain (loss) on available-for-sale securities, after-tax	(2)	0	(6)	(1)
Reclassification to net income on available for sale securities, after tax	1	(2)	1	(2)
Other comprehensive income (loss)	(19)	(34)	97	22
Comprehensive income	293	271	1,159	1,083
Net income attributable to noncontrolling interests	2	(2)	4	6
Other comprehensive income (loss) attributable to noncontrolling interests	(22)	(4)	(26)	(17)
Comprehensive income attributable to Kellogg Company	$ 313	$ 277	$ 1,181	$ 1,094

Consolidated Statement of Equit

Consolidated Statement of Equity (Unaudited) - USD ($) shares in Millions, $ in Millions	Total	Common stock	Capital in excess of par value	Retained earnings	Treasury stock	Accumulated other comprehensive income (loss)	Total Kellogg Company equity	Non-controlling interests
Balance (in shares) at Jan. 02, 2021		421			77
Balance at Jan. 02, 2021		$ 105	$ 972	$ 8,326	$ (4,559)	$ (1,732)	$ 3,112	$ 524
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Jan. 02, 2021	$ 3,636
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock repurchased	(240)				$ (240)		(240)
Common stock repurchased (in shares)					4
Net income	1,061			1,055			1,055	6
Acquisition of noncontrolling interest and other	52		22				22	30
Dividends, Common Stock	(590)			(590)			(590)
Distributions to noncontrolling interest	(18)						0	(18)
Other comprehensive income (loss)	22					39	39	(17)
Stock compensation	50		50				50
Stock options exercised and other	36		(39)	5	$ 70		36
Stock options exercised and other (in shares)					(1)
Balance (in shares) at Oct. 02, 2021		421			80
Balance at Oct. 02, 2021		$ 105	1,005	8,796	$ (4,729)	(1,693)	3,484	525
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Oct. 02, 2021	$ 4,009
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared - per share	$ 1.73
Balance (in shares) at Jul. 03, 2021		421			80
Balance at Jul. 03, 2021		$ 105	973	8,688	$ (4,741)	(1,663)	3,362	518
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Jul. 03, 2021	$ 3,880
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	305			307			307	(2)
Acquisition of noncontrolling interest and other	52		22				22	30
Dividends, Common Stock	(198)			(198)			(198)
Distributions to noncontrolling interest	(17)						0	(17)
Other comprehensive income (loss)	(34)					(30)	(30)	(4)
Stock compensation	11		11				11
Stock options exercised and other	10		(1)	(1)	$ 12		10
Stock options exercised and other (in shares)					0
Balance (in shares) at Oct. 02, 2021		421			80
Balance at Oct. 02, 2021		$ 105	1,005	8,796	$ (4,729)	(1,693)	3,484	525
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Oct. 02, 2021	$ 4,009
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared - per share	$ 0.58
Balance (in shares) at Jan. 01, 2022		421			80
Balance at Jan. 01, 2022	$ 3,720	$ 105	1,023	9,028	$ (4,715)	(1,721)	3,720	495
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Jan. 01, 2022	4,215
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock repurchased	(300)				$ (300)		(300)
Common stock repurchased (in shares)					5
Net income	1,062			1,058			1,058	4
Dividends, Common Stock	(596)			(596)			(596)
Distributions to noncontrolling interest	(18)						0	(18)
Other comprehensive income (loss)	97					123	123	(26)
Stock compensation	56		56				56
Stock options exercised and other	222		(52)	9	$ 265		222
Stock options exercised and other (in shares)					(5)
Balance (in shares) at Oct. 01, 2022		421			80
Balance at Oct. 01, 2022	4,283	$ 105	1,027	9,499	$ (4,750)	(1,598)	4,283	455
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Oct. 01, 2022	$ 4,738
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared - per share	$ 1.75
Balance (in shares) at Jul. 02, 2022		421			81
Balance at Jul. 02, 2022		$ 105	1,008	9,387	$ (4,817)	(1,601)	4,082	476
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Jul. 02, 2022	$ 4,558
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	312			310			310	2
Dividends, Common Stock	(202)			(202)			(202)
Distributions to noncontrolling interest	(1)						0	(1)
Other comprehensive income (loss)	(19)					3	3	(22)
Stock compensation	21		21				21
Stock options exercised and other	69		(2)	4	$ 67		69
Stock options exercised and other (in shares)					(1)
Balance (in shares) at Oct. 01, 2022		421			80
Balance at Oct. 01, 2022	4,283	$ 105	$ 1,027	$ 9,499	$ (4,750)	$ (1,598)	$ 4,283	$ 455
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Oct. 01, 2022	$ 4,738
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared - per share	$ 0.59

Consolidated Statement of Equ_2

Consolidated Statement of Equity Consolidated Statement of Equity (Unaudited) (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 01, 2022	Oct. 02, 2021
Statement of Stockholders' Equity [Abstract]
Dividends declared - per share	$ 0.59	$ 0.58	$ 1.75	$ 1.73

Consolidated Statement of Cash

Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021
Operating activities
Net income	$ 1,062	$ 1,061
Adjustments to reconcile net income to operating cash flows:
Depreciation and amortization	351	346
Postretirement benefit plan expense (benefit)	(189)	(112)
Deferred income taxes	26	4
Stock compensation	56	50
Other	(16)	(29)
Postretirement benefit plan contributions	(17)	(15)
Changes in operating assets and liabilities, net of acquisitions:
Trade receivables	(526)	(196)
Inventories	(343)	(103)
Accounts payable	501	198
All other current assets and liabilities	275	(59)
Net cash provided by (used in) operating activities	1,180	1,145
Investing activities
Additions to properties	(350)	(408)
Issuance of notes receivable	0	(29)
Repayments of notes receivable	10	28
Investments in unconsolidated entities	0	(10)
Purchases of available for sale securities	(15)	(56)
Sales of available for sale securities	14	69
Settlement of net investment hedges	37	10
Collateral paid on derivatives	(10)	(9)
Other	2	20
Net cash provided by (used in) investing activities	(312)	(385)
Financing activities
Net issuances (reductions) of notes payable	37	343
Issuances of long-term debt	0	361
Reductions of long-term debt	(33)	(646)
Net issuances of common stock	244	50
Common stock repurchases	(300)	(240)
Cash dividends	(596)	(590)
Other	(17)	(18)
Net cash provided by (used in) financing activities	(665)	(740)
Effect of exchange rate changes on cash and cash equivalents	(116)	(15)
Increase (decrease) in cash and cash equivalents	87	5
Cash and cash equivalents at beginning of period	286	435
Cash and cash equivalents at end of period	373	440
Supplemental cash flow disclosures of non-cash investing activities
Additions to properties included in accounts payable	$ 75	$ 91

Accounting Policies

Accounting Policies	9 Months Ended
	Oct. 01, 2022
Accounting Policies [Abstract]
Accounting Policies	Accounting policies Basis of presentation The unaudited interim financial information of Kellogg Company (the Company) included in this report reflects all adjustments, all of which are of a normal and recurring nature, that management believes are necessary for a fair statement of the results of operations, comprehensive income, financial position, equity and cash flows for the periods presented. This interim information should be read in conjunction with the financial statements and accompanying footnotes within the Company’s 2021 Annual Report on Form 10-K. The condensed balance sheet information at January 1, 2022 was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States. The results of operations for the quarter ended October 1, 2022 are not necessarily indicative of the results to be expected for other interim periods or the full year. Accounts payable - Supplier Finance Programs The Company has agreements with third parties to provide accounts payable tracking systems which facilitate participating suppliers’ ability to monitor and, if elected, sell payment obligations from the Company to designated third-party financial institutions. Participating suppliers may, at their sole discretion, make offers to sell one or more payment obligations of the Company prior to their scheduled due dates at a discounted price to participating financial institutions. The Company’s goal is to capture overall supplier savings, in the form of payment terms or vendor funding, and the agreements facilitate the suppliers’ ability to sell payment obligations, while providing them with greater working capital flexibility. The Company has no economic interest in the sale of these suppliers’ receivables and no direct financial relationship with the financial institutions concerning these services. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to sell amounts under the arrangements. However, the Company’s right to offset balances due from suppliers against payment obligations is restricted by the agreements for those payment obligations that have been sold by suppliers. The payment of these obligations by the Company is included in cash used in operating activities in the Consolidated Statement of Cash Flows. As of October 1, 2022, $1.1 billion of the Company’s outstanding payment obligations had been placed in the accounts payable tracking system. As of January 1, 2022, $905 million of the Company’s outstanding payment obligations had been placed in the accounts payable tracking system. Accounting standards to be adopted in future periods Supplier Finance Programs: Disclosure of Supplier Finance Program Obligations. In September 2022, the FASB issued an ASU to improve the disclosures of supplier finance programs. Specifically, the ASU requires disclosure of key terms of the supplier finance programs and a rollforward of the related obligations. The amendments in this ASU do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company has historically presented information regarding the nature and amount of outstanding Accounts Payable obligations confirmed into supplier finance programs within the Accounting Policies note of the financial statements. The Company is currently assessing the impact of any incremental disclosures required by this ASU and the planned timing of adoption.

Proposed separation transaction

Proposed separation transactions	9 Months Ended
	Oct. 01, 2022
Discontinued Operations and Disposal Groups [Abstract]
Proposed spin-off transaction [Text Block]	Proposed separation transactions On June 21, 2022, the Company announced its intent to separate its North American cereal and plant-based foods businesses, via tax-free spin-offs, with a target to complete the transactions by the end of 2023, resulting in three independent public companies, each better positioned to unlock their full standalone potential. While we announced a plan to separate our plant-based food business through a tax free spin-off, we are also exploring other strategic alternatives, including a possible sale. We cannot assure that the transactions will be completed on the anticipated timeline or at all or that the terms of the separations will not change. The transactions will follow the satisfaction of customary conditions, including reviews and final approval by Kellogg’s Board of Directors, receipt of an Internal Revenue Service ruling and relevant tax opinions with respect to the tax-free nature of the transactions, effectiveness of appropriate filings with the U.S. Securities and Exchange Commission, and the completion of audited financials of the new independent companies. The Company incurred charges related to the proposed separations of $18 million and $22 million for the quarter and year-to-date periods ended October 1, 2022, respectively, primarily related to legal and consulting costs.

Sale of Accounts Receivable

Sale of Accounts Receivable	9 Months Ended
	Oct. 01, 2022
Transfers and Servicing of Financial Assets [Abstract]
Transfers and Servicing of Financial Assets [Text Block]	Sale of accounts receivable The Company has a program in which a discrete group of customers are allowed to extend their payment terms in exchange for the elimination of early payment discounts (Extended Terms Program). The Company has two Receivable Sales Agreements (Monetization Programs) described below, which are intended to directly offset the impact the Extended Terms Program would have on the days-sales-outstanding (DSO) metric that is critical to the effective management of the Company's accounts receivable balance and overall working capital. The Monetization Programs sell, on a revolving basis, certain trade accounts receivable invoices to third party financial institutions. Transfers under these agreements are accounted for as sales of receivables resulting in the receivables being de-recognized from the Consolidated Balance Sheet. The Monetization Programs provide for the continuing sale of certain receivables on a revolving basis until terminated by either party; however the maximum receivables that may be sold at any time is approximately $745 million. During 2022 the Company amended the agreements to decrease the previous maximum receivables sold limit from approximately $1.1 billion as of January 1, 2022. The Company has no retained interest in the receivables sold, however the Company does have collection and administrative responsibilities for the sold receivables. The Company has not recorded any servicing assets or liabilities as of October 1, 2022 and January 1, 2022 for these agreements as the fair value of these servicing arrangements as well as the fees earned were not material to the financial statements. Accounts receivable sold of $632 million and $549 million remained outstanding under these arrangements as of October 1, 2022 and January 1, 2022, respectively. The proceeds from these sales of receivables are included in cash from operating activities in the Consolidated Statement of Cash Flows in the period of sale. The recorded net loss on sale of receivables was $6 million and $11 million for the quarter and year-to-date period ended October 1, 2022, respectively and was $2 million and $6 million for the quarter and year-to-date period ended October 2, 2021. The recorded loss is included in Other income and expense, net (OIE). Other programs

Equity

Equity	3 Months Ended
	Oct. 01, 2022
Equity [Abstract]
Equity	Equity Earnings per share Basic earnings per share is determined by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per share is similarly determined, except that the denominator is increased to include the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued. Dilutive potential common shares consist principally of employee stock options issued by the Company, restricted stock units, and certain contingently issuable performance shares. There were approximately 2 million and 4 million anti-dilutive potential common shares excluded from the calculation for the quarter and year-to-date periods ended October 1, 2022. There were approximately 8 million and 11 million anti-dilutive potential common shares excluded from the calculation for the quarter and year-to-date periods ended October 2, 2021. Please refer to the Consolidated Statement of Income for basic and diluted earnings per share for the quarter and year-to-date periods ended October 1, 2022 and October 2, 2021. Share repurchases In February 2020, the board of directors approved an authorization to repurchase up to $1.5 billion of our common stock through December 2022. During the year-to-date period ended October 1, 2022, the Company repurchased approxima tely 5 million shares of common stock for a total of $300 million. D uring the year-to-date period October 2, 2021, the Company repurchased approximately 4 million shares of common stock for a total of $240 million. Comprehensive income Comprehensive income includes net income and all other changes in equity during a period except those resulting from investments by or distributions to shareholders. Other comprehensive income consists of foreign currency translation adjustments, fair value adjustments associated with cash flow hedges, adjustments for net experience losses and prior service cost related to employee benefit plans, and adjustments for unrealized gains and losses on available-for-sale securities, net of related tax effects. Reclassifications out of Accumulated other comprehensive income (AOCI) for the quarter and year-to-date periods ended October 1, 2022 and October 2, 2021, consisted of the following: (millions) Details about AOCI Amount reclassified Line item impacted Quarter ended Year-to-date period ended (Gains) losses on cash flow hedges: Interest rate contracts (a) $ (14) $ (6) Interest expense $ (14) $ (6) Total before tax 3 1 Tax expense (benefit) $ (11) $ (5) Net of tax Amortization of postretirement and postemployment benefits: Net experience (gain) loss (b) $ — $ (2) OIE $ — $ (2) Total before tax — 1 Tax expense (benefit) $ — $ (1) Net of tax (Gains) losses on available-for-sale securities: Corporate bonds (a) $ 1 $ 1 OIE $ 1 $ 1 Total before tax — — Tax expense (benefit) $ 1 $ 1 Net of tax Total reclassifications $ (10) $ (5) Net of tax (millions) Details about AOCI Amount reclassified Line item impacted Quarter ended Year-to-date period ended (Gains) losses on cash flow hedges: Interest rate contracts (a) $ 4 $ 19 Interest expense $ 4 $ 19 Total before tax (1) (5) Tax expense (benefit) $ 3 $ 14 Net of tax Amortization of postretirement and postemployment benefits: Net experience (gain) loss (b) $ — $ (2) OIE $ — $ (2) Total before tax — 1 Tax expense (benefit) $ — $ (1) Net of tax (Gain) loss on available-for-sale securities: Corporate bonds (a) $ (2) $ (2) OIE $ (2) $ (2) Total before tax — — Tax expense (benefit) $ (2) $ (2) Net of tax Total reclassifications $ 1 $ 11 Net of tax (a) See Derivative instruments and fair value measurements note. (b) See Employee benefits note. Accumulated other comprehensive income (loss), net of tax, as of October 1, 2022 and January 1, 2022 consisted of the following: (millions) October 1, January 1, Foreign currency translation adjustments $ (2,225) $ (1,748) Net investment hedges gain (loss) 521 67 Cash flow hedges — unrealized net gain (loss) 139 (13) Postretirement and postemployment benefits: Net experience gain (loss) (2) (1) Prior service credit (cost) (26) (26) Available-for-sale securities unrealized net gain (loss) (5) — Total accumulated other comprehensive income (loss) $ (1,598) $ (1,721)

Employee Benefits

Employee Benefits	9 Months Ended
	Oct. 01, 2022
Retirement Benefits [Abstract]
Employee Benefits	Employee benefits The Company sponsors a number of U.S. and foreign pension plans as well as other nonpension postretirement and postemployment plans to provide various benefits for its employees. These plans are described within the footnotes to the Consolidated Financial Statements included in the Company’s 2021 Annual Report on Form 10-K. Components of Company benefit plan (income) expense for the periods presented are included in the tables below. Excluding the service cost component, these amounts are included within Other income (expense) in the Consolidated Statement of Income. Pension Quarter ended Year-to-date period ended (millions) October 1, 2022 October 2, 2021 October 1, 2022 October 2, 2021 Service cost $ 6 $ 9 $ 23 $ 27 Interest cost 34 25 91 75 Expected return on plan assets (57) (76) (200) (231) Amortization of unrecognized prior service cost 2 2 7 6 Recognized net (gain) loss (15) 83 (46) 63 Net periodic benefit cost $ (30) $ 43 $ (125) $ (60) Curtailment (gain) loss — (1) — (1) Total pension (income) expense $ (30) $ 42 $ (125) $ (61) Other nonpension postretirement Quarter ended Year-to-date period ended (millions) October 1, 2022 October 2, 2021 October 1, 2022 October 2, 2021 Service cost $ 2 $ 3 $ 8 $ 9 Interest cost 6 5 18 15 Expected return on plan assets (28) (23) (83) (69) Amortization of unrecognized prior service cost (2) (2) (7) (6) Total postretirement benefit (income) expense $ (22) $ (17) $ (64) $ (51) Postemployment Quarter ended Year-to-date period ended (millions) October 1, 2022 October 2, 2021 October 1, 2022 October 2, 2021 Service cost $ — $ 1 $ 2 $ 3 Interest cost 1 1 1 1 Recognized net experience (gain) loss — — (2) (2) Total postemployment benefit expense $ 1 $ 2 $ 1 $ 2 For the quarter and year-to-date periods ended October 1, 2022, the Company recognized a gain of $15 million and $46 million, respectively, rel ated to the remeasurement of two U.S. pension plans . For the quarter and year-to-date periods ended October 2, 2021, the Company recognized a loss of $83 million and $63 million, respectively, related to the remeasurement of two U.S. pension plans. These remeasurements were the result of distributions that exceeded service and interest costs resulting in settlement accounting for those specific plans. For the quarter and year-to-date periods ended October 1, 2022, remeasurements recognized were due primarily to an increase in the discount rate relative to the previous remeasurement date partially offset by lower than expected return on plan assets. Fiscal 2022 net periodic benefit cost for the U.S. pension plans was initially determined using a weighted average discount rate of 3.0%. As a result of the remeasurements, this rate has increased to 4.0%. For the quarter and year-to-date period ended October 2, 2021, remeasurements recognized were due primarily to lower than expected return on plan assets partially offset by an increase in the discount rate relative to the previous remeasurement date. Company contributions to employee benefit plans are summarized as follows: (millions) Pension Nonpension postretirement Total Quarter ended: October 1, 2022 $ 1 $ 4 $ 5 October 2, 2021 $ — $ 5 $ 5 Year-to-date period ended: October 1, 2022 $ 2 $ 15 $ 17 October 2, 2021 $ 2 $ 13 $ 15 Full year: Fiscal year 2022 (projected) $ 3 $ 17 $ 20 Fiscal year 2021 (actual) $ 4 $ 16 $ 20 Plan funding strategies may be modified in response to management's evaluation of tax deductibility, market conditions, and competing investment alternatives.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 01, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income taxes The consolidated effective tax rate for the quarters ended October 1, 2022 and October 2, 2021 was 19% and 24%, respectively. The consolidated effective tax rate for the year-to-date periods ended October 1, 2022 and October 2, 2021 was 21% and 25%, respectively. The lower effective tax rate for the quarter and year-to-date periods ended October 1, 2022, compared to the same periods in 2021, was due to a prior year increase in the United Kingdom (UK) tax rate and a prior year valuation allowance. During the third quarter of 2021, the Company determined that certain foreign deferred tax assets were no longer more likely than not to be realized in the future and a $20 million full valuation allowance was recorded on a discrete period basis. During the second quarter of 2021, the Company recorded tax expense of $23 million as a result of tax legislation enacted in the UK in June 2021, which increased the statutory UK tax rate from 19 percent to 25 percent for tax periods after April 1, 2023. The Company revalued its net deferred tax balances related to the UK business to reflect the increased tax rate. As of October 1, 2022, the Company classifie d $14 million of unr ecognized tax benefits as a net current tax liability. Management's estimate of reasonably possible changes in unrecognized tax benefits during the next twelve months consists of the current liability expected to be settled within one year, offset by appr oximately $3 million o f projected additions related primarily to ongoing intercompany transfer pricing activity. Management is currently unaware of any issues under review that could result in significant additional payments, accruals or other material deviation in this estimate. The Company’s total gross unrecognized tax benefits as of October 1, 2022 w as $52 million. Of this balance, $45 million represents the amount that, if recognized, would affect the Company’s effective income tax rate in future periods.

Derivative Instruments and Fair

Derivative Instruments and Fair Value Measurements	9 Months Ended
	Oct. 01, 2022
Derivative Instruments and Fair Value Measurements [Abstract]
Derivative Instruments and Fair Value Measurements	Derivative instruments and fair value measurements The Company is exposed to certain market risks such as changes in interest rates, foreign currency exchange rates, and commodity prices, which exist as a part of its ongoing business operations. Management uses derivative and nonderivative financial instruments and commodity instruments, including futures, options, and swaps, where appropriate, to manage these risks. Instruments used as hedges must be effective at reducing the risk associated with the exposure being hedged. The Company designates derivatives and nonderivative hedging instruments as cash flow hedges, fair value hedges, net investment hedges, and uses other contracts to reduce volatility in interest rates, foreign currency and commodities. As a matter of policy, the Company does not engage in trading or speculative hedging transactions. Derivative instruments are classified on the Consolidated Balance Sheet based on the contractual maturity of the instrument or the timing of the underlying cash flows of the instrument for derivatives with contractual maturities beyond one year. Any collateral associated with derivative instruments is classified as other assets or other current liabilities on the Consolidated Balance Sheet depending on whether the counterparty collateral is in an asset or liability position. Margin deposits related to exchange-traded commodities are recorded in accounts receivable, net on the Consolidated Balance Sheet. On the Consolidated Statement of Cash Flows, cash flows associated with derivative instruments are classified according to the nature of the underlying hedged item. Cash flows associated with collateral and margin deposits on exchange-traded commodities are classified as investing cash flows when the collateral account is in an asset position and as financing cash flows when the collateral account is in a liability position. Total notional amounts of the Company’s derivative instruments as of October 1, 2022 and January 1, 2022 were as follows: (millions) October 1, January 1, Foreign currency exchange contracts $ 3,308 $ 2,828 Cross-currency contracts 1,815 1,343 Interest rate contracts 2,579 2,816 Commodity contracts 362 360 Total $ 8,064 $ 7,347 Following is a description of each category in the fair value hierarchy and the financial assets and liabilities of the Company that were included in each category at October 1, 2022 and January 1, 2022, measured on a recurring basis. Level 1 – Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market. For the Company, level 1 financial assets and liabilities consist primarily of commodity derivative contracts. Level 2 – Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. For the Company, level 2 financial assets and liabilities consist of interest rate swaps, cross-currency swaps and over-the-counter commodity and currency contracts. The Company’s calculation of the fair value of interest rate swaps is derived from a discounted cash flow analysis based on the terms of the contract and the interest rate curve. Over-the-counter commodity derivatives are valued using an income approach based on the commodity index prices less the contract rate multiplied by the notional amount. Foreign currency contracts are valued using an income approach based on forward rates less the contract rate multiplied by the notional amount. Cross-currency contracts are valued based on changes in the spot rate at the time of valuation compared to the spot rate at the time of execution, as well as the change in the interest differential between the two currencies. The Company’s calculation of the fair value of level 2 financial assets and liabilities takes into consideration the risk of nonperformance, including counterparty credit risk. Level 3 – Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the asset or liability. The Company did not have any level 3 financial assets or liabilities as of October 1, 2022 or January 1, 2022. The following table presents assets and liabilities that were measured at fair value in the Consolidated Balance Sheet on a recurring basis as of October 1, 2022 and January 1, 2022: Derivatives designated as hedging instruments October 1, 2022 January 1, 2022 (millions) Level 1 Level 2 Total Level 1 Level 2 Total Assets: Cross-currency contracts: Other current assets $ — $ 82 $ 82 $ — $ 32 $ 32 Other assets — 202 202 — 15 15 Interest rate contracts(a): Other current assets — — — — 10 10 Other assets — 62 62 — 8 8 Total assets $ — $ 346 $ 346 $ — $ 65 $ 65 Liabilities: Cross-currency contracts: Other current liabilities $ — $ (1) $ (1) $ — $ (2) $ (2) Other liabilities — (5) (5) — (7) (7) Interest rate contracts: Other current liabilities — — — — (1) (1) Other liabilities — (86) (86) — (4) (4) Total liabilities $ — $ (92) $ (92) $ — $ (14) $ (14) (a) The fair value of the related hedged portion of the Company's long-term debt, a level 2 liability, was $1.0 billion as of October 1, 2022 and $1.2 billion as of January 1, 2022. Derivatives not designated as hedging instruments October 1, 2022 January 1, 2022 (millions) Level 1 Level 2 Total Level 1 Level 2 Total Assets: Foreign currency exchange contracts: Other current assets $ — $ 142 $ 142 $ — $ 18 $ 18 Other assets — 17 17 — 5 5 Interest rate contracts: Other current assets — 2 2 — 4 4 Other assets — 20 20 — — — Commodity contracts: Other current assets 5 — 5 5 — 5 Total assets $ 5 $ 181 $ 186 $ 5 $ 27 $ 32 Liabilities: Foreign currency exchange contracts: Other current liabilities $ — $ (126) $ (126) $ — $ (20) $ (20) Other liabilities — (10) (10) — (6) (6) Interest rate contracts: Other current liabilities — (4) (4) — (6) (6) Other liabilities — (24) (24) — (7) (7) Commodity contracts: Other current liabilities (10) — (10) (6) — (6) Total liabilities $ (10) $ (164) $ (174) $ (6) $ (39) $ (45) The Company has designated its outstanding foreign currency denominated debt as a net investment hedge of a portion of the Company’s investment in its subsidiaries’ foreign currency denominated net assets. The carrying value of this debt, including current and long-term, was approximately $2.0 billion as of October 1, 2022 and $2.4 billion as of January 1, 2022. The following amounts were recorded on the Consolidated Balance Sheet related to cumulative basis adjustments for existing fair value hedges as of October 1, 2022 and January 1, 2022. (millions) Line Item in the Consolidated Balance Sheet in which the hedged item is included Carrying amount of the hedged liabilities Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged liabilities (a) October 1, January 1, October 1, January 1, Interest rate contracts Current maturities of long-term debt $ 209 $ — $ (2) $ — Interest rate contracts Long-term debt $ 2,413 $ 2,903 $ (76) $ 12 (a) The fair value adjustment related to current maturities of long-term debt includes ($2) million from discontinued hedging relationships as of October 1, 2022. The fair value adjustment related to long-term debt includes $12 million and $13 million from discontinued hedging relationships as of October 1, 2022 and January 1, 2022, respectively. The Company has elected to not offset the fair values of derivative assets and liabilities executed with the same counterparty that are generally subject to enforceable netting agreements. However, if the Company were to offset and record the asset and liability balances of derivatives on a net basis, the amounts presented in the Consolidated Balance Sheet as of October 1, 2022 and January 1, 2022 would be adjusted as detailed in the following table: As of October 1, 2022: Gross Amounts Not Offset in the Amounts Financial Cash Collateral Net Total asset derivatives $ 532 $ (225) $ — $ 307 Total liability derivatives $ (266) $ 225 $ 40 $ (1) As of January 1, 2022: Gross Amounts Not Offset in the Amounts Financial Cash Collateral Net Total asset derivatives $ 97 $ (47) $ 8 $ 58 Total liability derivatives $ (59) $ 47 $ 12 $ — During the quarter and year-to-date periods ended October 1, 2022, the Company settled certain interest rate contracts resulting in a net realized gain of approximately $83 million and $165 million, respectively. These derivatives were accounted for as cash flow hedges and the related net gains were recorded in accumulated other comprehensive income and will be amortized to interest expense over the term of the related forecasted fixed rate debt, once issued. During the quarter ended October 1, 2022, the Company recognized an $18 million gain related to a portion of certain forward-starting interest rate swaps no longer designated as cash flow hedges due to changes in forecasted debt issuance. Additionally, during the year-to-date period ended October 1, 2022, the Company settled certain cross currency swaps resulting in a net gain of $37 million. T hese cross currency swaps were accounted for as net investment hedges and the related net gain was recorded in accumulated other comprehensive income. The effect of derivative instruments on the Consolidated Statements of Income and Comprehensive Income for the quarters ended October 1, 2022 and October 2, 2021 was as follows: Derivatives and non-derivatives in net investment hedging relationships (millions) Gain (loss) Gain (loss) excluded from assessment of hedge effectiveness Location of gain (loss) in income of excluded component October 1, October 2, October 1, October 2, Foreign currency denominated long-term debt $ 137 $ 57 $ — $ — Cross-currency contracts 123 30 11 5 Interest expense Total $ 260 $ 87 $ 11 $ 5 Derivatives not designated as hedging instruments (millions) Location of gain Gain (loss) October 1, October 2, Foreign currency exchange contracts COGS $ 14 $ 13 Foreign currency exchange contracts Other income (expense), net (9) (1) Foreign currency exchange contracts SG&A 3 1 Interest rate contracts Interest expense 1 — Commodity contracts COGS (1) 29 Total $ 8 $ 42 The effect of derivative instruments on the Consolidated Statements of Income and Comprehensive Income for the year-to-date periods ended October 1, 2022 and October 2, 2021 was as follows: Derivatives and non-derivatives in net investment hedging relationships (millions) Gain (loss) Gain (loss) excluded from assessment of hedge effectiveness Location of gain (loss) in income of excluded component October 1, October 2, October 1, October 2, Foreign currency denominated long-term debt $ 339 $ 128 $ — $ — Cross-currency contracts 277 47 28 15 Interest expense Total $ 616 $ 175 $ 28 $ 15 Derivatives not designated as hedging instruments (millions) Location of gain Gain (loss) October 1, October 2, Foreign currency exchange contracts COGS $ 34 $ (13) Foreign currency exchange contracts Other income (expense), net (18) (2) Foreign currency exchange contracts SGA 8 6 Interest rate contracts Interest expense 3 1 Commodity contracts COGS 33 96 Total $ 60 $ 88 The effect of fair value and cash flow hedge accounting on the Consolidated Income Statement for the quarters ended October 1, 2022 and October 2, 2021: October 1, 2022 October 2, 2021 (millions) Interest Expense Interest Expense Total amounts of income and expense line items presented in the Consolidated Income Statement in which the effects of fair value or cash flow hedges are recorded $ 39 $ 55 Gain (loss) on fair value hedging relationships: Interest contracts: Hedged items 35 3 Derivatives designated as hedging instruments (34) (2) Gain (loss) on cash flow hedging relationships: Interest contracts: Amount of gain (loss) reclassified from AOCI into income 14 (4) The effect of fair value and cash flow hedge accounting on the Consolidated Income Statement for the year-to-date periods ended October 1, 2022 and October 2, 2021: October 1, 2022 October 2, 2021 (millions) Interest Expense Interest Expense Total amounts of income and expense line items presented in the Consolidated Income Statement in which the effects of fair value or cash flow hedges are recorded $ 149 $ 172 Gain (loss) on fair value hedging relationships: Interest contracts: Hedged items 89 3 Derivatives designated as hedging instruments (85) (2) Gain (loss) on cash flow hedging relationships: Interest contracts: Amount of gain (loss) reclassified from AOCI into income 6 (19) During the next 12 months, the Company expects $18 million of net deferred losses reported in AOCI at October 1, 2022 to be reclassified to income, assuming market rates remain constant through contract maturities. Certain of the Company’s derivative instruments contain provisions requiring the Company to post collateral on those derivative instruments that are in a liability position if the Company’s credit rating is at or below BB+ (S&P), or Baa1 (Moody’s). The fair value of all derivative instruments with credit-risk-related contingent features in a liability position on October 1, 2022 was not material. In addition, certain derivative instruments contain provisions that would be triggered in the event the Company defaults on its debt agreements. There were no collateral posting requirements as of October 1, 2022 triggered by credit-risk-related contingent features. Other fair value measurements Available for sale securities October 1, 2022 January 1, 2022 Unrealized Unrealized (millions) Cost Gain (Loss) Market Value Cost Gain (Loss) Market Value Corporate bonds $ 52 $ (6) $ 46 $ 52 $ — $ 52 During the year-to-date period ended October 1, 2022, the Company sold approximately $14 million of investments in level 2 corporate bonds. The resulting loss was approximately $1 million and recorded in Other income and (expense). Also during the year-to-date period ended October 1, 2022, the Company purchased approximately $15 million in level 2 corporate bonds. During the year-to-date period ended October 2, 2021, the Company sold approximately $69 million of investments in level 2 corporate bonds. The resulting gain from the sale of these investments was approximately $2 million and recorded in Other income and (expense). Also during the year-to-date period ended October 2, 2021, the Company purchased approximately $56 million in level 2 corporate bonds. The market values of the Company's investments in level 2 corporate bonds are based on matrices or models from pricing vendors. Unrealized gains and losses are included in the Consolidated Statement of Comprehensive Income. Additionally, these investments are recorded within Other current assets and Other assets on the Consolidated Balance Sheet, based on the maturity of the individual security. The maturity dates of the securities range from 2024 to 2036. The Company reviews its investment portfolio for any unrealized losses that would be deemed other-than-temporary and requires the recognition of an impairment loss in earnings. If the cost of an investment exceeds its fair value, the Company evaluates, among other factors, general market conditions, the duration and extent to which the fair value is less than its cost, the Company's intent to hold the investment, and whether it is more likely than not that the Company will be required to sell the investment before recovery of the cost basis. The Company also considers the type of security, related industry and sector performance, and published investment ratings. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded and a new cost basis in the investment is established. If conditions within individual markets, industry segments, or macro-economic environments deteriorate, the Company could incur future impairments. Equity investments We hold equity investments in certain companies that we do not have the ability to exercise significant influence. Equity investments without a readily determinable fair value are recorded at original cost. Investments with a readily determinable fair value, which are level 2 investments, are measured at fair value based on observable market price changes, with gains and losses recorded through net earnings. Equity investments were approximately $40 million as of October 1, 2022 and January 1, 2022. Additionally, these investments were recorded within Other noncurrent assets on the Consolidated Balance Sheet. Financial instruments The carrying values of the Company’s short-term items, including cash, cash equivalents, accounts receivable, accounts payable, notes payable and current maturities of long-term debt approximate fair value. The fair value of the Company’s long-term debt, which are level 2 liabilities, is calculated based on broker quotes. The fair value and carrying value of the Company's long-term debt was $5.4 billion and $5.7 billion, respectively, as of October 1, 2022. The fair value and carrying value of the Company's long-term debt was $6.9 billion and $6.3 billion, respectively, as of January 1, 2022. Counterparty credit risk concentration and collateral requirements The Company is exposed to credit loss in the event of nonperformance by counterparties on derivative financial and commodity contracts. Management believes a concentration of credit risk with respect to derivative counterparties is limited due to the credit ratings and use of master netting and reciprocal collateralization agreements with the counterparties and the use of exchange-traded commodity contracts. Master netting agreements apply in situations where the Company executes multiple contracts with the same counterparty. Certain counterparties represent a concentration of credit risk to the Company. If those counterparties fail to perform according to the terms of derivative contracts, this would result in a loss to the Company of approximately $254 million, net of collateral already received from those counterparties, as of October 1, 2022. For certain derivative contracts, reciprocal collateralization agreements with counterparties call for the posting of collateral in the form of cash, treasury securities or letters of credit if a fair value loss position to the Company or its counterparties exceeds a certain amount. In addition, the Company is required to maintain cash margin accounts in connection with its open positions for exchange-traded commodity derivative instruments executed with the counterparty that are subject to enforceable netting agreements. As of October 1, 2022, the Company posted $34 million in margin deposits for exchange-traded commodity derivative instruments, which was reflected as an increase in accounts receivable, net on the Consolidated Balance Sheet. Management believes concentrations of credit risk with respect to accounts receivable is limited due to the generally high credit quality of the Company’s major customers, as well as the large number and geographic dispersion of smaller customers.

Reportable Segments

Reportable Segments	9 Months Ended
	Oct. 01, 2022
Segment Reporting [Abstract]
Reportable Segments	Reportable segments Kellogg Company is a leading producer of snacks, cereal, and frozen foods. It is the second largest producer of crackers, a leading producer of savory snacks, and the world's leading producer of cereal. Additional product offerings include toaster pastries, cereal bars, veggie foods and noodles. Kellogg products are manufactured and marketed globally. Principal markets for these products include the United States, United Kingdom, Nigeria, Canada, Mexico, and Australia. The Company manages its operations through four operating segments that are based on geographic location – North America which includes U.S. businesses and Canada; Europe which consists of European countries; Latin America which consists of Central and South America and includes Mexico; and AMEA (Asia Middle East Africa) which consists of Africa, Middle East, Australia and other Asian and Pacific markets. These operating segments also represent our reportable segments. Corporate includes corporate administration and initiatives as well as share-based compensation. The measurement of reportable segment results is based on segment operating profit which is generally consistent with the presentation of operating profit in the Consolidated Statement of Income. Reportable segment results were as follows: Quarter ended Year-to-date period ended (millions) October 1, October 2, October 1, October 2, Net sales North America $ 2,338 $ 2,056 $ 6,696 $ 6,199 Europe 562 631 1,749 1,827 Latin America 282 252 826 754 AMEA 767 683 2,217 1,981 Total Reportable Segments 3,949 3,622 11,488 10,761 Corporate (3) — (6) — Consolidated $ 3,946 $ 3,622 $ 11,482 $ 10,761 Operating profit North America $ 322 $ 328 $ 1,043 $ 1,070 Europe 75 96 280 277 Latin America 29 29 82 88 AMEA 64 60 192 186 Total Reportable Segments 490 513 1,597 1,621 Corporate (122) (66) (297) (198) Consolidated $ 368 $ 447 $ 1,300 $ 1,423 Supplemental product information is provided below for net sales to external customers: Quarter ended Year-to-date period ended (millions) October 1, October 2, October 1, October 2, Snacks $ 1,943 $ 1,712 $ 5,635 $ 5,015 Cereal 1,355 1,313 3,978 4,023 Frozen 281 277 829 841 Noodles and other 367 320 1,040 882 Consolidated $ 3,946 $ 3,622 $ 11,482 $ 10,761

Supplemental Financial Statemen

Supplemental Financial Statement Data	9 Months Ended
	Oct. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Supplemental Balance Sheet Disclosures [Text Block]	Supplemental Financial Statement Data Consolidated Balance Sheet (millions) October 1, 2022 (unaudited) January 1, 2022 Trade receivables $ 1,677 $ 1,240 Allowance for credit losses (12) (15) Refundable income taxes 88 62 Other receivables 232 202 Accounts receivable, net $ 1,985 $ 1,489 Raw materials and supplies $ 422 $ 383 Finished goods and materials in process 1,260 1,015 Inventories $ 1,682 $ 1,398 Intangible assets not subject to amortization $ 1,957 $ 2,031 Intangible assets subject to amortization, net 345 378 Other intangibles, net $ 2,302 $ 2,409

Accounting Policies (Policies)

Accounting Policies (Policies)	9 Months Ended
	Oct. 01, 2022
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The unaudited interim financial information of Kellogg Company (the Company) included in this report reflects all adjustments, all of which are of a normal and recurring nature, that management believes are necessary for a fair statement of the results of operations, comprehensive income, financial position, equity and cash flows for the periods presented. This interim information should be read in conjunction with the financial statements and accompanying footnotes within the Company’s 2021 Annual Report on Form 10-K. The condensed balance sheet information at January 1, 2022 was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States. The results of operations for the quarter ended October 1, 2022 are not necessarily indicative of the results to be expected for other interim periods or the full year.
Accounts payable	Accounts payable - Supplier Finance ProgramsThe Company has agreements with third parties to provide accounts payable tracking systems which facilitate participating suppliers’ ability to monitor and, if elected, sell payment obligations from the Company to designated third-party financial institutions. Participating suppliers may, at their sole discretion, make offers to sell one or more payment obligations of the Company prior to their scheduled due dates at a discounted price to participating financial institutions. The Company’s goal is to capture overall supplier savings, in the form of payment terms or vendor funding, and the agreements facilitate the suppliers’ ability to sell payment obligations, while providing them with greater working capital flexibility. The Company has no economic interest in the sale of these suppliers’ receivables and no direct financial relationship with the financial institutions concerning these services. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to sell amounts under the arrangements. However, the Company’s right to offset balances due from suppliers against payment obligations is restricted by the agreements for those payment obligations that have been sold by suppliers.

Equity (Tables)

Equity (Tables)	9 Months Ended
	Oct. 01, 2022
Equity [Abstract]
Reclassifications Out of AOCI	Reclassifications out of Accumulated other comprehensive income (AOCI) for the quarter and year-to-date periods ended October 1, 2022 and October 2, 2021, consisted of the following: (millions) Details about AOCI Amount reclassified Line item impacted Quarter ended Year-to-date period ended (Gains) losses on cash flow hedges: Interest rate contracts (a) $ (14) $ (6) Interest expense $ (14) $ (6) Total before tax 3 1 Tax expense (benefit) $ (11) $ (5) Net of tax Amortization of postretirement and postemployment benefits: Net experience (gain) loss (b) $ — $ (2) OIE $ — $ (2) Total before tax — 1 Tax expense (benefit) $ — $ (1) Net of tax (Gains) losses on available-for-sale securities: Corporate bonds (a) $ 1 $ 1 OIE $ 1 $ 1 Total before tax — — Tax expense (benefit) $ 1 $ 1 Net of tax Total reclassifications $ (10) $ (5) Net of tax (millions) Details about AOCI Amount reclassified Line item impacted Quarter ended Year-to-date period ended (Gains) losses on cash flow hedges: Interest rate contracts (a) $ 4 $ 19 Interest expense $ 4 $ 19 Total before tax (1) (5) Tax expense (benefit) $ 3 $ 14 Net of tax Amortization of postretirement and postemployment benefits: Net experience (gain) loss (b) $ — $ (2) OIE $ — $ (2) Total before tax — 1 Tax expense (benefit) $ — $ (1) Net of tax (Gain) loss on available-for-sale securities: Corporate bonds (a) $ (2) $ (2) OIE $ (2) $ (2) Total before tax — — Tax expense (benefit) $ (2) $ (2) Net of tax Total reclassifications $ 1 $ 11 Net of tax
Summary of Accumulated Other Comprehensive Income (Loss)	Accumulated other comprehensive income (loss), net of tax, as of October 1, 2022 and January 1, 2022 consisted of the following: (millions) October 1, January 1, Foreign currency translation adjustments $ (2,225) $ (1,748) Net investment hedges gain (loss) 521 67 Cash flow hedges — unrealized net gain (loss) 139 (13) Postretirement and postemployment benefits: Net experience gain (loss) (2) (1) Prior service credit (cost) (26) (26) Available-for-sale securities unrealized net gain (loss) (5) — Total accumulated other comprehensive income (loss) $ (1,598) $ (1,721)

Employee Benefits (Tables)

Employee Benefits (Tables)	9 Months Ended
	Oct. 01, 2022
Retirement Benefits [Abstract]
Components of Plan Benefit Expense	Pension Quarter ended Year-to-date period ended (millions) October 1, 2022 October 2, 2021 October 1, 2022 October 2, 2021 Service cost $ 6 $ 9 $ 23 $ 27 Interest cost 34 25 91 75 Expected return on plan assets (57) (76) (200) (231) Amortization of unrecognized prior service cost 2 2 7 6 Recognized net (gain) loss (15) 83 (46) 63 Net periodic benefit cost $ (30) $ 43 $ (125) $ (60) Curtailment (gain) loss — (1) — (1) Total pension (income) expense $ (30) $ 42 $ (125) $ (61) Other nonpension postretirement Quarter ended Year-to-date period ended (millions) October 1, 2022 October 2, 2021 October 1, 2022 October 2, 2021 Service cost $ 2 $ 3 $ 8 $ 9 Interest cost 6 5 18 15 Expected return on plan assets (28) (23) (83) (69) Amortization of unrecognized prior service cost (2) (2) (7) (6) Total postretirement benefit (income) expense $ (22) $ (17) $ (64) $ (51) Postemployment Quarter ended Year-to-date period ended (millions) October 1, 2022 October 2, 2021 October 1, 2022 October 2, 2021 Service cost $ — $ 1 $ 2 $ 3 Interest cost 1 1 1 1 Recognized net experience (gain) loss — — (2) (2) Total postemployment benefit expense $ 1 $ 2 $ 1 $ 2
Contributions to Employee Benefit Plans	Company contributions to employee benefit plans are summarized as follows: (millions) Pension Nonpension postretirement Total Quarter ended: October 1, 2022 $ 1 $ 4 $ 5 October 2, 2021 $ — $ 5 $ 5 Year-to-date period ended: October 1, 2022 $ 2 $ 15 $ 17 October 2, 2021 $ 2 $ 13 $ 15 Full year: Fiscal year 2022 (projected) $ 3 $ 17 $ 20 Fiscal year 2021 (actual) $ 4 $ 16 $ 20

Derivative Instruments and Fa_2

Derivative Instruments and Fair Value Measurements (Tables)	9 Months Ended
	Oct. 01, 2022
Derivative Instruments and Fair Value Measurements [Abstract]
Schedule of Total Notional Amounts of Derivative Instruments	Total notional amounts of the Company’s derivative instruments as of October 1, 2022 and January 1, 2022 were as follows: (millions) October 1, January 1, Foreign currency exchange contracts $ 3,308 $ 2,828 Cross-currency contracts 1,815 1,343 Interest rate contracts 2,579 2,816 Commodity contracts 362 360 Total $ 8,064 $ 7,347
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	The following table presents assets and liabilities that were measured at fair value in the Consolidated Balance Sheet on a recurring basis as of October 1, 2022 and January 1, 2022: Derivatives designated as hedging instruments October 1, 2022 January 1, 2022 (millions) Level 1 Level 2 Total Level 1 Level 2 Total Assets: Cross-currency contracts: Other current assets $ — $ 82 $ 82 $ — $ 32 $ 32 Other assets — 202 202 — 15 15 Interest rate contracts(a): Other current assets — — — — 10 10 Other assets — 62 62 — 8 8 Total assets $ — $ 346 $ 346 $ — $ 65 $ 65 Liabilities: Cross-currency contracts: Other current liabilities $ — $ (1) $ (1) $ — $ (2) $ (2) Other liabilities — (5) (5) — (7) (7) Interest rate contracts: Other current liabilities — — — — (1) (1) Other liabilities — (86) (86) — (4) (4) Total liabilities $ — $ (92) $ (92) $ — $ (14) $ (14) (a) The fair value of the related hedged portion of the Company's long-term debt, a level 2 liability, was $1.0 billion as of October 1, 2022 and $1.2 billion as of January 1, 2022. Derivatives not designated as hedging instruments October 1, 2022 January 1, 2022 (millions) Level 1 Level 2 Total Level 1 Level 2 Total Assets: Foreign currency exchange contracts: Other current assets $ — $ 142 $ 142 $ — $ 18 $ 18 Other assets — 17 17 — 5 5 Interest rate contracts: Other current assets — 2 2 — 4 4 Other assets — 20 20 — — — Commodity contracts: Other current assets 5 — 5 5 — 5 Total assets $ 5 $ 181 $ 186 $ 5 $ 27 $ 32 Liabilities: Foreign currency exchange contracts: Other current liabilities $ — $ (126) $ (126) $ — $ (20) $ (20) Other liabilities — (10) (10) — (6) (6) Interest rate contracts: Other current liabilities — (4) (4) — (6) (6) Other liabilities — (24) (24) — (7) (7) Commodity contracts: Other current liabilities (10) — (10) (6) — (6) Total liabilities $ (10) $ (164) $ (174) $ (6) $ (39) $ (45)
Schedule of Derivative Instruments in Statement of Financial Position Fair Value	The following amounts were recorded on the Consolidated Balance Sheet related to cumulative basis adjustments for existing fair value hedges as of October 1, 2022 and January 1, 2022. (millions) Line Item in the Consolidated Balance Sheet in which the hedged item is included Carrying amount of the hedged liabilities Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged liabilities (a) October 1, January 1, October 1, January 1, Interest rate contracts Current maturities of long-term debt $ 209 $ — $ (2) $ — Interest rate contracts Long-term debt $ 2,413 $ 2,903 $ (76) $ 12 (a) The fair value adjustment related to current maturities of long-term debt includes ($2) million from discontinued hedging relationships as of October 1, 2022. The fair value adjustment related to long-term debt includes $12 million and $13 million from discontinued hedging relationships as of October 1, 2022 and January 1, 2022, respectively.
Schedule of Offsetting Assets	As of October 1, 2022: Gross Amounts Not Offset in the Amounts Financial Cash Collateral Net Total asset derivatives $ 532 $ (225) $ — $ 307 Total liability derivatives $ (266) $ 225 $ 40 $ (1) As of January 1, 2022: Gross Amounts Not Offset in the Amounts Financial Cash Collateral Net Total asset derivatives $ 97 $ (47) $ 8 $ 58 Total liability derivatives $ (59) $ 47 $ 12 $ —
Schedule of Offsetting Liabilities	As of October 1, 2022: Gross Amounts Not Offset in the Amounts Financial Cash Collateral Net Total asset derivatives $ 532 $ (225) $ — $ 307 Total liability derivatives $ (266) $ 225 $ 40 $ (1) As of January 1, 2022: Gross Amounts Not Offset in the Amounts Financial Cash Collateral Net Total asset derivatives $ 97 $ (47) $ 8 $ 58 Total liability derivatives $ (59) $ 47 $ 12 $ —
Schedule of the Effect of Derivative Instruments on the Consolidated Statements of Income and Comprehensive Income	The effect of derivative instruments on the Consolidated Statements of Income and Comprehensive Income for the quarters ended October 1, 2022 and October 2, 2021 was as follows: Derivatives and non-derivatives in net investment hedging relationships (millions) Gain (loss) Gain (loss) excluded from assessment of hedge effectiveness Location of gain (loss) in income of excluded component October 1, October 2, October 1, October 2, Foreign currency denominated long-term debt $ 137 $ 57 $ — $ — Cross-currency contracts 123 30 11 5 Interest expense Total $ 260 $ 87 $ 11 $ 5 Derivatives not designated as hedging instruments (millions) Location of gain Gain (loss) October 1, October 2, Foreign currency exchange contracts COGS $ 14 $ 13 Foreign currency exchange contracts Other income (expense), net (9) (1) Foreign currency exchange contracts SG&A 3 1 Interest rate contracts Interest expense 1 — Commodity contracts COGS (1) 29 Total $ 8 $ 42 The effect of derivative instruments on the Consolidated Statements of Income and Comprehensive Income for the year-to-date periods ended October 1, 2022 and October 2, 2021 was as follows: Derivatives and non-derivatives in net investment hedging relationships (millions) Gain (loss) Gain (loss) excluded from assessment of hedge effectiveness Location of gain (loss) in income of excluded component October 1, October 2, October 1, October 2, Foreign currency denominated long-term debt $ 339 $ 128 $ — $ — Cross-currency contracts 277 47 28 15 Interest expense Total $ 616 $ 175 $ 28 $ 15 Derivatives not designated as hedging instruments (millions) Location of gain Gain (loss) October 1, October 2, Foreign currency exchange contracts COGS $ 34 $ (13) Foreign currency exchange contracts Other income (expense), net (18) (2) Foreign currency exchange contracts SGA 8 6 Interest rate contracts Interest expense 3 1 Commodity contracts COGS 33 96 Total $ 60 $ 88 The effect of fair value and cash flow hedge accounting on the Consolidated Income Statement for the quarters ended October 1, 2022 and October 2, 2021: October 1, 2022 October 2, 2021 (millions) Interest Expense Interest Expense Total amounts of income and expense line items presented in the Consolidated Income Statement in which the effects of fair value or cash flow hedges are recorded $ 39 $ 55 Gain (loss) on fair value hedging relationships: Interest contracts: Hedged items 35 3 Derivatives designated as hedging instruments (34) (2) Gain (loss) on cash flow hedging relationships: Interest contracts: Amount of gain (loss) reclassified from AOCI into income 14 (4) The effect of fair value and cash flow hedge accounting on the Consolidated Income Statement for the year-to-date periods ended October 1, 2022 and October 2, 2021: October 1, 2022 October 2, 2021 (millions) Interest Expense Interest Expense Total amounts of income and expense line items presented in the Consolidated Income Statement in which the effects of fair value or cash flow hedges are recorded $ 149 $ 172 Gain (loss) on fair value hedging relationships: Interest contracts: Hedged items 89 3 Derivatives designated as hedging instruments (85) (2) Gain (loss) on cash flow hedging relationships: Interest contracts: Amount of gain (loss) reclassified from AOCI into income 6 (19)
Schedule of Available-for-sale Securities Reconciliation	October 1, 2022 January 1, 2022 Unrealized Unrealized (millions) Cost Gain (Loss) Market Value Cost Gain (Loss) Market Value Corporate bonds $ 52 $ (6) $ 46 $ 52 $ — $ 52

Reportable Segments (Tables)

Reportable Segments (Tables)	9 Months Ended
	Oct. 01, 2022
Segment Reporting [Abstract]
Schedule of Reportable Segment Information	Reportable segment results were as follows: Quarter ended Year-to-date period ended (millions) October 1, October 2, October 1, October 2, Net sales North America $ 2,338 $ 2,056 $ 6,696 $ 6,199 Europe 562 631 1,749 1,827 Latin America 282 252 826 754 AMEA 767 683 2,217 1,981 Total Reportable Segments 3,949 3,622 11,488 10,761 Corporate (3) — (6) — Consolidated $ 3,946 $ 3,622 $ 11,482 $ 10,761 Operating profit North America $ 322 $ 328 $ 1,043 $ 1,070 Europe 75 96 280 277 Latin America 29 29 82 88 AMEA 64 60 192 186 Total Reportable Segments 490 513 1,597 1,621 Corporate (122) (66) (297) (198) Consolidated $ 368 $ 447 $ 1,300 $ 1,423
Revenue from External Customers by Products and Services	Supplemental product information is provided below for net sales to external customers: Quarter ended Year-to-date period ended (millions) October 1, October 2, October 1, October 2, Snacks $ 1,943 $ 1,712 $ 5,635 $ 5,015 Cereal 1,355 1,313 3,978 4,023 Frozen 281 277 829 841 Noodles and other 367 320 1,040 882 Consolidated $ 3,946 $ 3,622 $ 11,482 $ 10,761

Supplemental Financial Statem_2

Supplemental Financial Statement Data (Tables)	9 Months Ended
	Oct. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Supplemental Financial Data Consolidated Balance Sheet [Table Text Block]	Consolidated Balance Sheet (millions) October 1, 2022 (unaudited) January 1, 2022 Trade receivables $ 1,677 $ 1,240 Allowance for credit losses (12) (15) Refundable income taxes 88 62 Other receivables 232 202 Accounts receivable, net $ 1,985 $ 1,489 Raw materials and supplies $ 422 $ 383 Finished goods and materials in process 1,260 1,015 Inventories $ 1,682 $ 1,398 Intangible assets not subject to amortization $ 1,957 $ 2,031 Intangible assets subject to amortization, net 345 378 Other intangibles, net $ 2,302 $ 2,409

Accounting Policies - Narrative

Accounting Policies - Narrative (Details) - USD ($) $ in Millions	Oct. 01, 2022	Jan. 01, 2022
Accounting Policies [Abstract]
Obligations placed in accounts payable tracking system	$ 1,100	$ 905

Proposed separation transacti_2

Proposed separation transactions (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Oct. 01, 2022	Oct. 01, 2022
Discontinued Operations and Disposal Groups [Abstract]
Proposed separation transaction related costs	$ 18	$ 22

Sale of Accounts Receivable - N

Sale of Accounts Receivable - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 01, 2022	Oct. 02, 2021	Jan. 01, 2022
Monetization Program | Other income (expense)
Transfer of Financial Assets Accounted for as Sales [Line Items]
Gain (Loss) on Sale of Accounts Receivable	$ (6)	$ (2)	$ (11)	$ (6)
Monetization Program | Maximum [Member]
Transfer of Financial Assets Accounted for as Sales [Line Items]
Transfers of Accounts Receivable Agreements	745		745		$ 1,100
Monetization Program | Sold And Outstanding
Transfer of Financial Assets Accounted for as Sales [Line Items]
Transfer of Financial Assets Accounted for as Sales, Amount Derecognized	632		632		549
Kellogg Foreign Subsidiaries Other Program
Transfer of Financial Assets Accounted for as Sales [Line Items]
Transfers of Accounts Receivable Agreements	$ 36		$ 36		$ 66

Equity - Narrative (Details)

Equity - Narrative (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 01, 2022	Oct. 02, 2021	Feb. 29, 2020
Equity, Class of Treasury Stock [Line Items]
Anti-dilutive potential common shares excluded from reconciliation	2	8	4	11
Common stock repurchased			$ 300	$ 240
February 2020 Share Repurchase Program
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program, authorized amount					$ 1,500
Common stock repurchased (in shares)			5	4
Common stock repurchased			$ 300	$ 240

Equity - Reclassifications Out

Equity - Reclassifications Out of AOCI (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Oct. 01, 2022	Oct. 02, 2021	Oct. 01, 2022	Oct. 02, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Interest expense		$ 39	$ 55	$ 149	$ 172
Net experience (gain) loss		0	0	2	2
Other income (expense), net		54	0	188	155
Total before tax		383	392	1,339	1,406
Tax expense (benefit)		(74)	(92)	(283)	(345)
Net income		312	305	1,062	1,061
Reclassification out of Accumulated Other Comprehensive Income
Derivative Instruments, Gain (Loss) [Line Items]
Net income		(10)	1	(5)	11
Reclassification out of Accumulated Other Comprehensive Income | (Gains) losses on cash flow hedges
Derivative Instruments, Gain (Loss) [Line Items]
Total before tax		(14)	4	(6)	19
Tax expense (benefit)		3	(1)	1	(5)
Net income		(11)	3	(5)	14
Reclassification out of Accumulated Other Comprehensive Income | (Gains) losses on cash flow hedges | Interest rate contracts
Derivative Instruments, Gain (Loss) [Line Items]
Interest expense	[1]	(14)	4	(6)	19
Reclassification out of Accumulated Other Comprehensive Income | Amortization of postretirement and postemployment benefits
Derivative Instruments, Gain (Loss) [Line Items]
Total before tax		0	0	(2)	(2)
Tax expense (benefit)		0	0	1	1
Net income		0	0	(1)	(1)
Reclassification out of Accumulated Other Comprehensive Income | Amortization of postretirement and postemployment benefits | Other income (expense)
Derivative Instruments, Gain (Loss) [Line Items]
Net experience (gain) loss	[2]	0	0	(2)	(2)
Corporate bonds | Reclassification out of Accumulated Other Comprehensive Income | (Gains) losses on available-for-sale securities
Derivative Instruments, Gain (Loss) [Line Items]
Total before tax		1	(2)	1	(2)
Tax expense (benefit)		0	0	0	0
Net income		1	(2)	1	(2)
Corporate bonds | Reclassification out of Accumulated Other Comprehensive Income | (Gains) losses on available-for-sale securities | Other income (expense)
Derivative Instruments, Gain (Loss) [Line Items]
Other income (expense), net	[1]	$ 1	$ (2)	$ 1	$ (2)
[1]See Derivative instruments and fair value measurements note.[2]See Employee benefits note.

Equity - Summary of Accumulated

Equity - Summary of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	Oct. 01, 2022	Jan. 01, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Foreign currency translation adjustments	$ (2,225)	$ (1,748)
Net investment hedges gain (loss)	521	67
Cash flow hedges — unrealized net gain (loss)	139	(13)
Postretirement and postemployment benefits:
Net experience gain (loss)	(2)	(1)
Prior service credit (cost)	(26)	(26)
Available-for-sale securities unrealized net gain (loss)	(5)	0
Total accumulated other comprehensive income (loss)	$ (1,598)	$ (1,721)

Employee Benefits - Components

Employee Benefits - Components of Plan Benefit Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 01, 2022	Oct. 02, 2021
Pension | Global Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 6	$ 9	$ 23	$ 27
Interest cost	34	25	91	75
Expected return on plan assets	(57)	(76)	(200)	(231)
Amortization of unrecognized prior service cost (gain)	2	2	7	6
Recognized net (gain) loss	(15)	83	(46)	63
Net periodic benefit cost	(30)	43	(125)	(60)
Curtailment (gain) loss	0	(1)	0	(1)
Total plan benefit (income) expense	(30)	42	(125)	(61)
Other Nonpension Postretirement | U.S. and Canada
Defined Benefit Plan Disclosure [Line Items]
Service cost	2	3	8	9
Interest cost	6	5	18	15
Expected return on plan assets	(28)	(23)	(83)	(69)
Amortization of unrecognized prior service cost (gain)	(2)	(2)	(7)	(6)
Total plan benefit (income) expense	(22)	(17)	(64)	(51)
Postemployment | Global Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	0	1	2	3
Interest cost	1	1	1	1
Recognized net (gain) loss	0	0	(2)	(2)
Total plan benefit (income) expense	$ 1	$ 2	$ 1	$ 2

Employee Benefits - Component_2

Employee Benefits - Components of Plan Benefit Expense Narrative (Details) - UNITED STATES - Pension - USD ($) $ in Millions	3 Months Ended			9 Months Ended
	Oct. 01, 2022	Apr. 02, 2022	Oct. 02, 2021	Oct. 01, 2022	Oct. 02, 2021
Defined Benefit Plan Disclosure [Line Items]
Recognized net (gain) loss	$ (15)		$ 83	$ (46)	$ 63
Weighted-average discount rate		3%		4%

Employee Benefits - Contributio

Employee Benefits - Contributions to Employee Benefit Plans (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 01, 2022	Oct. 02, 2021	Jan. 01, 2022
Defined Benefit Plan Disclosure [Line Items]
Employer contributions to employee benefit plans	$ 5	$ 5	$ 17	$ 15	$ 20
Total current year projected employer contributions	20		20
Global Plans | Pension
Defined Benefit Plan Disclosure [Line Items]
Employer contributions to employee benefit plans	1	0	2	2	4
Total current year projected employer contributions	3		3
U.S. and Canada | Nonpension postretirement
Defined Benefit Plan Disclosure [Line Items]
Employer contributions to employee benefit plans	4	$ 5	15	$ 13	$ 16
Total current year projected employer contributions	$ 17		$ 17

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Jul. 03, 2021	Oct. 01, 2022	Oct. 02, 2021
Income Tax Contingency [Line Items]
Effective income tax rate	19%	24%		21%	25%
Income taxes	$ 74	$ 92		$ 283	$ 345
Unrecognized tax benefits	52			52
Projected additions to unrecognized tax benefits	3			3
Unrecognized tax benefits that would affect the effective income tax rate	45			45
Income tax related interest accrued	8			8
Valuation allowance foreign deferred tax assets		$ 20			$ 20
UNITED KINGDOM
Income Tax Contingency [Line Items]
Income taxes			$ 23
UNITED KINGDOM | Minimum [Member]
Income Tax Contingency [Line Items]
Effective income tax rate			19%
UNITED KINGDOM | Maximum [Member]
Income Tax Contingency [Line Items]
Effective income tax rate			25%
Other current liabilities
Income Tax Contingency [Line Items]
Unrecognized tax benefits	$ 14			$ 14

Derivative Instruments and Fa_3

Derivative Instruments and Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 01, 2022	Oct. 02, 2021
Derivative [Line Items]
Net deferred losses reported in AOCI to be reclassified into income in the next twelve months			$ (18)
Collateral posted	$ 0		0
Gain (loss) recognized in AOCI	260	$ 87	616	$ 175
Unrealized gain (loss) on cash flow hedges, pre-tax	62	3	213	42
Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure			254
Reclassification to net income, pre-tax	14	(4)	6	(19)
Net Investment Hedging
Derivative [Line Items]
Gain (loss) recognized in AOCI	260	87	616	175
Exchange-traded commodity
Derivative [Line Items]
Margin deposits	34		34
Cross currency interest rate contract | Net Investment Hedging
Derivative [Line Items]
Gain (loss) recognized in AOCI			37
Interest expense | Cash Flow Hedging
Derivative [Line Items]
Unrealized gain (loss) on cash flow hedges, pre-tax	83		165
Reclassification to net income, pre-tax	18
Interest expense | Cross currency interest rate contract | Net Investment Hedging
Derivative [Line Items]
Gain (loss) recognized in AOCI	$ 123	$ 30	$ 277	$ 47

Derivative Instruments and Fa_4

Derivative Instruments and Fair Value Measurements - Schedule of Total Notional Amounts of Derivative Instruments (Details) - USD ($) $ in Millions	Oct. 01, 2022	Jan. 01, 2022
Derivatives, Fair Value [Line Items]
Notional amount of derivative	$ 8,064	$ 7,347
Foreign currency exchange contracts
Derivatives, Fair Value [Line Items]
Notional amount of derivative	3,308	2,828
Cross currency interest rate contract
Derivatives, Fair Value [Line Items]
Notional amount of derivative	1,815	1,343
Interest rate contracts
Derivatives, Fair Value [Line Items]
Notional amount of derivative	2,579	2,816
Commodity contracts
Derivatives, Fair Value [Line Items]
Notional amount of derivative	$ 362	$ 360

Derivative Instruments and Fa_5

Derivative Instruments and Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Millions		Oct. 01, 2022	Jan. 01, 2022
Derivatives, Fair Value [Line Items]
Fair Value Of Related Hedge Portion Of Long Term Debt		$ 1,000	$ 1,200
Long-term debt total, carrying value		5,700	6,300
Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		346	65
Liabilities		(92)	(14)
Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		186	32
Liabilities		(174)	(45)
Level 1 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		0	0
Liabilities		0	0
Level 1 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		5	5
Liabilities		(10)	(6)
Level 2 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		346	65
Liabilities		(92)	(14)
Level 2 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		181	27
Liabilities		(164)	(39)
Cross currency interest rate contract | Other current assets | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		82	32
Cross currency interest rate contract | Other current assets | Level 1 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		0	0
Cross currency interest rate contract | Other current assets | Level 2 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		82	32
Cross currency interest rate contract | Other assets | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		202	15
Cross currency interest rate contract | Other assets | Level 1 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		0	0
Cross currency interest rate contract | Other assets | Level 2 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		202	15
Cross currency interest rate contract | Other current liabilities | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		(1)	(2)
Cross currency interest rate contract | Other current liabilities | Level 1 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		0	0
Cross currency interest rate contract | Other current liabilities | Level 2 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		(1)	(2)
Cross currency interest rate contract | Other liabilities | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		(5)	(7)
Cross currency interest rate contract | Other liabilities | Level 1 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		0	0
Cross currency interest rate contract | Other liabilities | Level 2 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		(5)	(7)
Foreign currency exchange contracts | Other current assets | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		142	18
Foreign currency exchange contracts | Other current assets | Level 1 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		0	0
Foreign currency exchange contracts | Other current assets | Level 2 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		142	18
Foreign currency exchange contracts | Other assets | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		17	5
Foreign currency exchange contracts | Other assets | Level 1 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		0	0
Foreign currency exchange contracts | Other assets | Level 2 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		17	5
Foreign currency exchange contracts | Other current liabilities | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		(126)	(20)
Foreign currency exchange contracts | Other current liabilities | Level 1 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		0	0
Foreign currency exchange contracts | Other current liabilities | Level 2 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		(126)	(20)
Foreign currency exchange contracts | Other liabilities | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		(10)	(6)
Foreign currency exchange contracts | Other liabilities | Level 1 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		0	0
Foreign currency exchange contracts | Other liabilities | Level 2 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		(10)	(6)
Interest rate contracts | Other current assets | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		0	10
Interest rate contracts | Other current assets | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		2	4
Interest rate contracts | Other current assets | Level 1 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		0	0
Interest rate contracts | Other current assets | Level 1 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		0	0
Interest rate contracts | Other current assets | Level 2 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets	[1]	0	10
Interest rate contracts | Other current assets | Level 2 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		2	4
Interest rate contracts | Other assets | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		62	8
Interest rate contracts | Other assets | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		20	0
Interest rate contracts | Other assets | Level 1 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		0	0
Interest rate contracts | Other assets | Level 1 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		0	0
Interest rate contracts | Other assets | Level 2 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets	[1]	62	8
Interest rate contracts | Other assets | Level 2 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		20	0
Interest rate contracts | Other current liabilities | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		0	(1)
Interest rate contracts | Other current liabilities | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		(4)	(6)
Interest rate contracts | Other current liabilities | Level 1 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		0	0
Interest rate contracts | Other current liabilities | Level 1 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		0	0
Interest rate contracts | Other current liabilities | Level 2 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		0	(1)
Interest rate contracts | Other current liabilities | Level 2 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		(4)	(6)
Interest rate contracts | Other liabilities | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		(86)	(4)
Interest rate contracts | Other liabilities | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		(24)	(7)
Interest rate contracts | Other liabilities | Level 1 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		0	0
Interest rate contracts | Other liabilities | Level 1 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		0	0
Interest rate contracts | Other liabilities | Level 2 | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		(86)	(4)
Interest rate contracts | Other liabilities | Level 2 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		(24)	(7)
Commodity contracts | Other current assets | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		5	5
Commodity contracts | Other current assets | Level 1 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		5	5
Commodity contracts | Other current assets | Level 2 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Assets		0	0
Commodity contracts | Other current liabilities | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		(10)	(6)
Commodity contracts | Other current liabilities | Level 1 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		(10)	(6)
Commodity contracts | Other current liabilities | Level 2 | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Liabilities		0	0
Net Investment Hedging
Derivatives, Fair Value [Line Items]
Long-term debt total, carrying value		$ 2,000	$ 2,400
[1]The fair value of the related hedged portion of the Company's long-term debt, a level 2 liability, was $1.0 billion as of October 1, 2022 and $1.2 billion as of January 1, 2022.

Derivative Instruments and Fa_6

Derivative Instruments and Fair Value Measurements - Schedule of Cumulative Basis Adjustments for Fair Value Hedges (Details) - USD ($) $ in Millions		Oct. 01, 2022	Jan. 01, 2022
Derivatives, Fair Value [Line Items]
Current maturities of long-term debt		$ 816	$ 712
Long-term debt		5,697	6,262
Carrying amount of hedged liability | Fair Value Hedges | Interest rate contracts | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Current maturities of long-term debt		209	0
Long-term debt		2,413	2,903
Cumulative fair value adjustment | Fair Value Hedges | Interest rate contracts | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Current maturities of long-term debt	[1]	(2)	0
Long-term debt	[1]	(76)	12
Hedging adjustment | Discontinued Hedges | Interest rate contracts
Derivatives, Fair Value [Line Items]
Current maturities of long-term debt		(2)
Long-term debt		$ 12	$ 13
[1]The fair value adjustment related to current maturities of long-term debt includes ($2) million from discontinued hedging relationships as of October 1, 2022. The fair value adjustment related to long-term debt includes $12 million and $13 million from discontinued hedging relationships as of October 1, 2022 and January 1, 2022, respectively.

Derivative Instruments and Fa_7

Derivative Instruments and Fair Value Measurements - Schedule of Offsetting Assets and Liabilities (Details) - USD ($) $ in Millions	Oct. 01, 2022	Jan. 01, 2022
Offsetting [Abstract]
Asset derivatives, Amounts Presented in the Consolidated Balance Sheet	$ 532	$ 97
Asset derivatives, Financial Instruments, Gross Amounts Not Offset in the Consolidated Balance Sheet	(225)	(47)
Asset derivatives, Cash Collateral Posted, Gross Amounts Not Offset in the Consolidated Balance Sheet	0	8
Asset derivatives, Net Amount	307	58
Liability derivatives, Amounts Presented in the Consolidated Balance Sheet	(266)	(59)
Liability derivatives, Financial Instruments, Gross Amounts Not Offset in the Consolidated Balance Sheet	225	47
Liability derivatives, Cash Collateral Received, Gross Amounts Not Offset in the Consolidated Balance Sheet	40	12
Liability derivatives, net amount	$ (1)	$ 0

Derivative Instruments and Fa_8

Derivative Instruments and Fair Value Measurements - Effect of Derivative Instruments on the Consolidated Statements of Income and Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 01, 2022	Oct. 02, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in AOCI	$ 260	$ 87	$ 616	$ 175
Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in income	8	42	60	88
Not Designated as Hedging Instrument | Foreign currency exchange contracts | COGS
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in income	14	13	34	(13)
Not Designated as Hedging Instrument | Foreign currency exchange contracts | Selling, General and Administrative Expenses
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in income	3	1	8	6
Not Designated as Hedging Instrument | Foreign currency exchange contracts | Interest expense
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in income	1	0	3	1
Not Designated as Hedging Instrument | Foreign currency exchange contracts | Other income (expense), net
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in income	(9)	(1)	(18)	(2)
Not Designated as Hedging Instrument | Commodity contracts | COGS
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in income	(1)	29	33	96
Net Investment Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in AOCI	260	87	616	175
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	11	5	28	15
Net Investment Hedging | Foreign currency denominated long-term debt
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in AOCI	137	57	339	128
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0	0	0
Net Investment Hedging | Cross currency interest rate contract
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in AOCI			37
Net Investment Hedging | Cross currency interest rate contract | Interest expense
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in AOCI	123	30	277	47
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	$ 11	$ 5	$ 28	$ 15

Derivative Instruments and Fa_9

Derivative Instruments and Fair Value Measurements - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on Consolidated Statement of Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 01, 2022	Oct. 02, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Interest Expense, Debt	$ 39	$ 55	$ 149	$ 172
Interest rate contracts | Designated as Hedging Instrument | Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) reclassified from AOCI into income	14	(4)	6	(19)
Interest rate contracts | Interest expense | Designated as Hedging Instrument | Fair Value Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Hedged items	35	3	89	3
Derivatives designated as hedging instruments	$ (34)	$ (2)	$ (85)	$ (2)

Derivative Instruments and F_10

Derivative Instruments and Fair Value Measurements - Schedule of Other Fair Value Measurements (Details) - USD ($) $ in Millions	9 Months Ended		12 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Jan. 01, 2022
Debt Securities, Available-for-sale [Line Items]
Sales of available for sale securities	$ 14	$ 69
Purchases of available for sale securities	15	56
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, amortized cost	52		$ 52
Available-for-sale securities, unrealized gain (loss)	(6)		0
Available-for-sale securities, market value	46		$ 52
Level 2 | Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Gain (loss) on sale of available-for-sale securities	(1)	2
Sales of available for sale securities	14	69
Purchases of available for sale securities	$ 15	$ 56

Derivative Instruments and F_11

Derivative Instruments and Fair Value Measurements - Equity Investments (Details) - USD ($) $ in Millions	Oct. 01, 2022	Jan. 01, 2022
Other assets | Level 2
Derivatives, Fair Value [Line Items]
Equity investments	$ 40	$ 40

Derivative Instruments and F_12

Derivative Instruments and Fair Value Measurements - Schedule of Fair Value of Long-term Debt (Details) - USD ($) $ in Billions	Oct. 01, 2022	Jan. 01, 2022
Derivative Instruments and Fair Value Measurements [Abstract]
Long-term debt, fair value	$ 5.4	$ 6.9
Long-term debt total, carrying value	$ 5.7	$ 6.3

Reportable Segments (Details)

Reportable Segments (Details) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2022 USD ($)	Oct. 02, 2021 USD ($)	Oct. 01, 2022 USD ($)	Oct. 02, 2021 USD ($)
Segment Reporting Information [Line Items]
Number of operating segments			4
Net sales	$ 3,946	$ 3,622	$ 11,482	$ 10,761
Operating profit	368	447	1,300	1,423
Operating Segments
Segment Reporting Information [Line Items]
Net sales	3,949	3,622	11,488	10,761
Operating profit	490	513	1,597	1,621
Operating Segments | North America
Segment Reporting Information [Line Items]
Net sales	2,338	2,056	6,696	6,199
Operating profit	322	328	1,043	1,070
Operating Segments | Europe
Segment Reporting Information [Line Items]
Net sales	562	631	1,749	1,827
Operating profit	75	96	280	277
Operating Segments | Latin America
Segment Reporting Information [Line Items]
Net sales	282	252	826	754
Operating profit	29	29	82	88
Operating Segments | AMEA
Segment Reporting Information [Line Items]
Net sales	767	683	2,217	1,981
Operating profit	64	60	192	186
Corporate
Segment Reporting Information [Line Items]
Net sales	(3)	0	(6)	0
Operating profit	$ (122)	$ (66)	$ (297)	$ (198)

Reportable Segments Supplementa

Reportable Segments Supplemental Product Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021	Oct. 01, 2022	Oct. 02, 2021
Segment Reporting Information [Line Items]
Net sales	$ 3,946	$ 3,622	$ 11,482	$ 10,761
Snacks
Segment Reporting Information [Line Items]
Net sales	1,943	1,712	5,635	5,015
Cereal
Segment Reporting Information [Line Items]
Net sales	1,355	1,313	3,978	4,023
Frozen
Segment Reporting Information [Line Items]
Net sales	281	277	829	841
Noodles and other
Segment Reporting Information [Line Items]
Net sales	$ 367	$ 320	$ 1,040	$ 882

Supplemental Financial Statem_3

Supplemental Financial Statement Data - Consolidated Balance Sheet (Unaudited) (Details) - USD ($) $ in Millions	Oct. 01, 2022	Jan. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Trade receivables	$ 1,677	$ 1,240
Allowance for credit losses	(12)	(15)
Refundable income taxes	88	62
Other receivables	232	202
Accounts receivable, net	1,985	1,489
Raw materials and supplies	422	383
Finished goods and materials in process	1,260	1,015
Inventories	1,682	1,398
Intangible assets not subject to amortization	1,957	2,031
Intangible assets subject to amortization, net	345	378
Other intangibles, net	$ 2,302	$ 2,409